Filter
1274
Text search:
Tuberculosis
impact
indicator
Featured
109
432
Language
Document type
847
212
101
48
41
12
5
3
3
2
Countries / Regions
55
53
41
41
39
39
38
33
31
30
30
29
29
29
28
26
23
22
21
20
18
18
16
14
13
12
11
11
11
10
9
7
7
7
7
6
6
6
5
5
5
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
641
74
69
42
40
13
9
Toolboxes
171
160
55
38
27
24
24
24
21
19
17
17
16
14
9
9
8
5
4
3
2
1
1
Health Policy and Planning, Volume 35, Issue 1, February 2020, Pages 47–57, https://doi.org/10.1093/heapol/czz122
Colombia has an underreporting of 30% of the total cases, according to World Health Organization (WHO) estimations. In 2016, successful tub
...
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e
...
4–15 February 2013
Tackling Tuberculosis in Under-Served Populations: A Resource for TB Control Boards and their partners
10–21 March 2014
Tuberculosis Infection Control Guidelines
recommended
Second Edition
Copenhagen, Denmark, 24–25 August 2017
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculos
...
Tuberculosis (TB) is an infectious disease that usually affects the lungs, though it can affect any organ in the body. It can develop when bacteria spread through droplets in the air. TB can be fatal, but in many cases, TB is preventable and treatab
...
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
